The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway

被引:46
作者
Gemmill, RM
Bemis, LT
Lee, JP
Sozen, MA
Baron, A
Zeng, C
Erickson, PF
Hooper, JE
Drabkin, HA
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Med Oncol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Cellular & Struct Biol, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA
关键词
TRC8; VHL; renal cell carcinoma; JAB1/CSN-5; patched; RING-H2; finger;
D O I
10.1038/sj.onc.1205437
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
VHL is part of an SCF related E3-ubiquitin ligase complex with 'gatekeeper' function in renal carcinoma. However, no mutations have been identified in VHL interacting proteins in wild type VHL tumors. We previously reported that the TRC8 gene was interrupted by a t(3;8) translocation in a family with hereditary renal and non-medullary thyroid cancer. TRC8 encodes a multi-membrane spanning protein containing a RING-H2 finger with in vitro ubiquitin ligase activity. We isolated the Drosophila homologue, DTrc8, and studied its function by genetic manipulations and a yeast 2-hybrid screen. Human and Drosophila TRC8 proteins localize to the endoplasmic reticulum. Loss of either DTrc8 or DVhl resulted in an identical ventral midline defect. Direct interaction between DTrc8 and DVhl was confirmed by GST-pulldown and co-immunoprecipitation experiments. CSN-5/JAB1 is a component of the COP9 signalosome, recently shown to regulate SCF function. We found that DTrc8 physically interacts with CSN-5 and that human JAB1 localization is dependent on VHL mutant status. Lastly, overexpression of DTrc8 inhibited growth consistent with its presumed role as a tumor suppressor gene. Thus, VHL, TRC8, and JAB1 appear to be linked both physically and functionally and all three may participate in the development of kidney cancer.
引用
收藏
页码:3507 / 3516
页数:10
相关论文
共 49 条
[1]   Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila [J].
Adryan, B ;
Decker, HJH ;
Papas, TS ;
Hsu, T .
ONCOGENE, 2000, 19 (24) :2803-2811
[2]   Structure of cDNAs encoding human eukaryotic initiation factor 3 subunits - Possible roles in RNA binding and macromolecular assembly [J].
Asano, K ;
Vornlocher, HP ;
RichterCook, NJ ;
Merrick, WC ;
Hinnebusch, AG ;
Hershey, JWB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27042-27052
[3]   Jab1 interacts directly with HIF-1α and regulates its stability [J].
Bae, MK ;
Ahn, MY ;
Jeong, JW ;
Bae, MH ;
Lee, YM ;
Bae, SK ;
Park, JW ;
Kim, KR ;
Kim, KW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :9-12
[4]   Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation [J].
Bays, NW ;
Gardner, RG ;
Seelig, LP ;
Joazeiro, CA ;
Hampton, RY .
NATURE CELL BIOLOGY, 2001, 3 (01) :24-29
[5]   Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity [J].
Bianchi, E ;
Denti, S ;
Granata, A ;
Bossi, G ;
Geginat, J ;
Villa, A ;
Rogge, L ;
Pardi, R .
NATURE, 2000, 404 (6778) :617-+
[6]  
BRAND AH, 1993, DEVELOPMENT, V118, P401
[7]   PTEN expression is reduced in a subset of sporadic thyroid carcinomas:: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1 [J].
Bruni, P ;
Boccia, A ;
Baldassarre, G ;
Trapasso, F ;
Santoro, M ;
Chiappetta, G ;
Fusco, A ;
Viglietto, G .
ONCOGENE, 2000, 19 (28) :3146-3155
[8]   JAB1 interacts with both the progesterone receptor and SRC-1 [J].
Chauchereau, A ;
Georgiakaki, M ;
Perrin-Wolff, M ;
Milgrom, E ;
Loosfelt, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8540-8548
[9]   A new group of conserved coactivators that increase the specificity of AP-1 transcription factors [J].
Claret, FX ;
Hibi, M ;
Dhut, S ;
Toda, T ;
Karin, M .
NATURE, 1996, 383 (6599) :453-457
[10]   The pVHL-associated SCF ubiquitin ligase complex:: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma [J].
Clifford, SC ;
Astuti, D ;
Hooper, L ;
Maxwell, PH ;
Ratcliffe, PJ ;
Maher, ER .
ONCOGENE, 2001, 20 (36) :5067-5074